HBIO Harvard Bioscience Inc.
1,036
$3.43
$0.04
(1.18%)
| Watchers | 1,036 |
| 52-Wk Low | $3.33 |
| 52-Wk High | $6.20 |
| Market Cap | $148.96M |
| Volume | 97,727.00 |
| 52-Wk High | $6.20 |
| 52-Wk Low | $3.33 |
Harvard Bioscience Sets Incentive Plan for Top ExecutivesTipRanks Financial Blog • about 2 months ago
Harvard Bioscience (HBIO) has provided an announcement. Harvard Bioscience, Inc.'s Compensation Committee has recently greenlit the 2024 annual cas...
Share to Feed
HOLLISTON, Mass., March 11, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, will be presenting to investors at...
This is a Bullish indicator signaling HBIO's price could rise from here. Traders may explore going long the stock or buying call options...
Related Stocks: NAS:HBIO...
Harvard Bioscience, Inc. 2023 Q4 - Results - Earnings Call Presentation...
Q4 Revenues of $28.2 millionQ4 Gross Margin of 58.0% (230 bps year-over-year improvement)Q4 operating income of $0.3 million, adjusted operating income of $3.3 millionStrong operating cash flow...
Harvard Bioscience, Inc. (HBIO) Q4 2023 Earnings Call Transcript...
Harvard Bioscience (NASDAQ:HBIO) est cens e publier ses derniers b n fices ce jeudi. Voici l'opinion de Benzinga\ sur le rapport de r sultats quatri me trimestre de Harvard Bioscience.
R sultat net...
Solutions for CROs, pharma and biotechs improve throughput and efficiency and enable future advancements in data analyticsHOLLISTON, Mass., March 06, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience...
This price move could indicate a change in the trend, and may be a buy signal for investors...